Results 111 to 120 of about 35,915 (205)

Management of adverse events in TB care and active TB drug safety monitoring. [PDF]

Breathe (Sheff)
Ma'aruf SY, Sharma A, Fox S, Duarte R, Lange C, Tiberi S.   +5 more
europepmc   +1 more source

Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]

J Clin Tuberc Other Mycobact Dis
Timboe K, Jackson JB, Becker GL.
europepmc   +1 more source

Tuberculose resistente: revisão molecular

Revista de Saúde Pública
O progresso na compreensão dos mecanismos de resistência aos fármacos usados no tratamento da tuberculose tem permitido o desenvolvimento de novos métodos para a detecção da tuberculose resistente.
Maria Lúcia Rosa Rossetti, Andréia Rosane de Moura Valim, Márcia Susana Nunes Silva, Vívian Sumnienski Rodrigues   +3 more
doaj  

Side Effects of First-Line Anti-tubercular Therapy (ATT): Does an Alternative Regimen Exist? [PDF]

Cureus
Goswami G, Nirala P, Tandon R, Kalra P, Tariq M, Singh L.   +5 more
europepmc   +1 more source

Anti-Tubercular Drug-Induced Liver Injury: Current Understanding and Emerging Directions. [PDF]

JGH Open
Prasad S, Narang H, Kedia S, Ahuja V.
europepmc   +1 more source

Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report. [PDF]

BMC Infect Dis
Schreurs H, Dejaegher J, Decroo T, André E, Lorent N, Henckaerts L.   +5 more
europepmc   +1 more source

Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure. [PDF]

PLoS One
Jayanti RP, Cho YS, Soedarsono S, Kim HJ, Kang J, Kim J, Oh JY, Kang BH, Ha JH, Kim JW, Mertaniasih NM, Kusmiati T, Permatasari A, Yuliwulandari R, Kim R, Seong HJ, Ghim JL, Kim DH, Shin JG, cPMTb.   +19 more
europepmc   +1 more source

Extensively drug-resistant tuberculosis in Togo: first reported cases and implications for tuberculosis control. [PDF]

IJID Reg
Zoutené M, Ako AME, Aziagbe KA, Gateu Tadjom NV, Adambounou TAS, Adjoh KS.   +5 more
europepmc   +1 more source

Analysis of factors influencing plasma concentrations of anti-TB drugs in pediatric TB patients. [PDF]

BMC Infect Dis
Huang Y, Guo Q, Wen Y, Liao Q, Wan C, Zhu Y.   +5 more
europepmc   +1 more source

Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico. [PDF]

PLoS One
Hernández-Ibarra JA, Mercado-Torres TR, Ruiz-Ruiz JR, Román-Montes CM, Rajme-López S, Martínez-Guerra A, González-Lara F, Rivera-Villegas HO, Guy Z, Roblero-Abadía ADC, de-León AP, Sifuentes-Osornio J, Tamez-Torres KM.   +12 more
europepmc   +1 more source